Press Release: Mydecine Secures Financing and Provides Company Update on Clinical Trials, Drug Development and Technology Initiatives
Cannabis Law Report
DECEMBER 9, 2021
The Financing will allow the Company to continue progressing its R&D, clinical trials and technology initiatives. “I I firmly believe the current downtrend in the industry is an overreaction to incredibly positive results from Compass Pathways 2b trial, which have clearly been misinterpreted. DENVER, Dec.
Let's personalize your content